Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 109, Issue 5, 2010, Pages

  Kostakis, George C ^a   Papadogeorgakis, Nikos ^b   Koumaki, Vasiliki ^c   Kamakari, Smaragda ^d   Koumaki, Dimitra ^c   Alexandridis, Constantinos ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c Papadimitriou Hospital   (Greece)

^d Biogenomica Laboratory   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; GUANINE; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; THYMINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; DNA SEQUENCE; ENZYMOLOGY; EXON; FEMALE; GENETIC POLYMORPHISM; GENETICS; GINGIVA TUMOR; GREECE; HUMAN; INTRON; MALE; MANDIBLE TUMOR; MIDDLE AGED; MOUTH MUCOSA; MOUTH TUMOR; MUTATION; PATHOLOGY; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOSINE; EXONS; FEMALE; GINGIVAL NEOPLASMS; GREECE; GUANINE; HUMANS; INTRONS; MALE; MANDIBULAR NEOPLASMS; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; THYMINE; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77951251423     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2010.01.015     Document Type: Article

References (33)

1. Macfarlane G.J., Boyle P., Evstifeeva T.V., Robertson C., and Scully C. Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem. Cancer Causes Control 5 (1994) 259-265
2. Tryggvason G., and Sveinsson T.E. Head and neck squamous cell cancer. Laeknabladid 95 10 (2009) 671-680
3. Gebhart E., and Liehr T. Patterns of genomic imbalances in human solid tumors. Int J Oncol 16 (2000) 383-399
4. Bockmuhl U., Wolf G., Schmidt S., Schwendel A., Jahnke V., Dietel M., et al. Head Neck 20 (1998) 145-1
5. Bader A.G., Kang S., Zhao L., and Vogt P.K. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5 (2005) 921-929
6. Samuels Y., and Ericson K. Oncogenic PI3K and its role in cancer. Curr Opin Oncol 18 (2006) 77-82
7. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
8. Karakas B., Bachman K.E., and Park B.H. Mutation of the PIK3CA oncogene in human cancers. Br J Cancer 27 (2006) 94 :455-9
9. Broderick D.K., Di C., Parret T.J., Samuels Y.R., Cummins J.M., Mc Lenton R.E., et al. Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas and medulloblastomas. Cancer Res 64 (2004) 5048-5050
10. Cambell I.G., Russell S.E., Choong D.Y., Montgomery K.G., Ciavarella M.L., Hooi C.S., et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64 (2004) 7678-7681
11. Lee J.W., Soung Y.H., Kim S.Y., Lee H.W., Park W.S., Nam S.W., et al. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 24 (2005) 1477-1480
12. Li V.S., Wong C.W., Chan T.L., Chan A.S., Zhao W., Chu K.M., et al. Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer 5 (2005) 29
13. Tanaka Y., Kanai F., Tada M., Asaoka Y., Guleng B., Jazag A., et al. Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients. Oncogene 11 (2006) 2950-2952
14. Samuels Y., Wang Z., Bardelli A., Sillman N., Ptak J., Szabo S., et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304 (2004) 554
15. Samuels Y., Diaz Jr. L.A., Schmidt-Kittler O., Cummins J.M., Delong L., Cheong I., et al. Mutant PIK3CA promotes cell growth and invasion of human cell cancer. Cancer Cell 7 (2005) 561-573
16. Estilo C.L., O-charoenrat P., Ngai I., Patel S.G., Reddy G., Dao S., et al. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110a in squamous cell carcinoma of the oral tongue. Clin Cancer Res 9 (2003) 2300-2306
17. Qiu W., Schonleben F., Li X., Ho D.J., Close L.G., Manolidis S., et al. PIK3CA mutations in head and neck squamous cell carcinoma. Clin Cancer Res 12 (2006) 1441-1446
18. Kozaki K., Imoto I., Pimkhaokham A., Hasegawa S., Tsuda H., Omura K., et al. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma. Cancer Sci 97 (2006) 1351-1358
19. Murugan A.K., Hong N.T., Fukui Y., Munirajan A.K., and Tsuchida N. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas. Int J Oncol 32 (2008) 101-111
20. Fenic I., Steger K., Gruber C., Arens C., and Woenckhaus J. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma. Oncol Rep 18 (2007) 253-259
21. In: Booth P.W., Schendel S.A., and Hausamen J.-E. (Eds). Maxillofacial surgery (2007), Churchill Livingstone, London 299-304
22. E!Ensembl. Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha. http://www.ensembl.org/Homo_sapiens/Gene/Sequence?g=ENSG00000121879;time =1267870382212.212 Accessed March 2010.
23. Levine D.A.B., Yee C.J., Lash A., Barakat R.R., Borgen P.Y., et al. Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res 11 (2005) 2875-2878
24. Shayesteh L., Lu Y., Kuo W.L., Balbocci R., Godfrey T., Collins S., et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21 (1999) 99-102
25. Wang Y., Helland A., Holm R., Kristensen G.B., and Borresen-Dale A.L. PIK3CA mutations in advanced ovarian carcinomas. Hum Mutat 25 (2005) 322
26. Qiu W., Tong G.X., Manolidis S., Close L.G., Assad A.M., and Su G.H. Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer. Int J Cancer 122 5 (2007) 1189-1194
27. Curtis A.P., and Houston T.X. Racial differences in the androgen/androgen receptor pathway in prostate cancer. J Natl Med Assoc 91 (1999) 653-660
28. Haffty B.G., Silber A., Matloff E., Chung J., and Lannin D. Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women. Med Genet 43 (2006) 133-137
29. Lai H., Lai S., Ma F., Meng L., and Trapido E. Prevalence and spectrum of p53 mutations in white Hispanic and non-Hispanic women with breast cancer. Breast Cancer Res Treat 81 1 (2003) 53-60
30. Shigematsu H., Lin L., Takahashi T., Nomura M., Suzuki M., Ignacio I., et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97 (2005) 339-346
31. Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha. http://snp500cancer.nci.nih.gov/snp.cfm?both_snp_id=PIK3CA-60 Accessed September 2008.
32. Holsinger F.S., Zuniga E.R., and Roberts. Squamous cell carcinoma. Head Neck 25 4 (2003) 267-273
33. Shah J. Head and neck surgery and oncology (2003), Mosby, London 232